Management dilemmas in pediatric nephrology: time-limited trials of dialysis therapy.
Aaron G WightmanPublished in: Pediatric nephrology (Berlin, Germany) (2016)
• Time-limited trials offer potential benefits in terms of alleviating the burden of decision-making in the setting of uncertainty, offering an opportunity to forecast a poor prognosis, help avoid interprofessional conflict, and providing support for patients, their families, and staff. • Time-limited trials have important limitations, including the use of time limits, difficulty in determining clear, meaningful endpoints, and different interpretations of a trial of therapy between parents and providers. • Decisions regarding the initiation, withholding, and withdrawal of dialysis should be made based on regular assessments of the benefits and burdens of the intervention for the child. • Pediatric nephrologists are better served to abandon the concept of time-limited trials.
Keyphrases
- end stage renal disease
- poor prognosis
- chronic kidney disease
- peritoneal dialysis
- long non coding rna
- randomized controlled trial
- ejection fraction
- newly diagnosed
- clinical trial
- mental health
- study protocol
- patient safety
- prognostic factors
- phase ii
- mesenchymal stem cells
- risk assessment
- quality improvement
- long term care
- replacement therapy
- double blind